Phospholipase A2 in serum and colonic mucosa in ulcerative colitis

REFERENCES

• Mayer RJ, Marshall LA. New insights on mammalian phospholipase A2(s); comparison of arachidonoyl-selective and -nonselective enzymes. Faseb J 1993; 7: 339–48.
   PubMed Web of Science ®Google Scholar
• Chock SP, Rhee SG, Tang LC, Schmauder Chock EA. Linking phospholipase A2 to phospholipid turnover and prostaglandin synthesis in mast-cell granules. Eur J Biochem 1991; 195: 707–13.
   Google Scholar
• Pruzanski W, Vadas P. Phospholipase A2-a mediator between proximal and distal effectors of inflammation. Immunol Today 1991; 12: 143–6.
   PubMedGoogle Scholar
• Forst S, Weiss J, Elsbach P, Maraganore JM, Reardon I, Heinrikson RL. Structural and func-tional properties of a phospholipase A2 purified from an inflammatory exudate. Biochemistry 1986; 25: 8381–5.
   PubMed Web of Science ®Google Scholar
• Harwig SS, Tan L, Qu XD, Cho Y, Eisenhauer PB, Lehrer RI. Bactericidal properties of murine intestinal phospholipase A2. J Clin Invest 1995; 95: 603–10.
   PubMed Web of Science ®Google Scholar
• Madsen LM, Inada M, Weiss J. Determinants of activation by complement of group II phospho-lipase A2 acting against Escherichia coli. Infect Immun 1996; 64: 2425–30.
   Google Scholar
• Heinrikson RL, Krueger ET, Keim PS. Amino acid sequence of phospholipase A2-alpha from the venom of Crotalus adamanteus. A new classifica-tion of phospholipases A2 based upon structural determinants. J Biol Chem 1977; 252: 4913–21.
   Google Scholar
• Dennis EA. The growing phospholipase A2 super-family of signal transduction enzymes. Trends Biochem Sci 1997; 22: 1–2.
   PubMed Web of Science ®Google Scholar
• Chen J, Engle SJ, Seilhamer JJ, Tischfield JA. Cloning and recombinant expression of a novel human low molecular weight Ca(2+)-dependent phospholipase A2. J Biol Chem 1994; 269: 2365–8.
   PubMed Web of Science ®Google Scholar
• Recklies AD, White C. phospholipase A2 is a major component of the salt-extractable pool of matrix proteins in adult human articular cartilage. Arthritis Rheum 1991; 34: 1106–15.
   PubMed Web of Science ®Google Scholar
• Nevalainen TJ, Märki F, Kortesuo PT, Grätter MG, Di Marco S, Schmitz A. Synovial type (group II) phospholipase A2 in cartilage. J Rheumatol 1993; 20: 325–30.
   PubMed Web of Science ®Google Scholar
• Kiyohara H, Egami H, Shibata Y, Murata K, Ohshima S, Ogawa M. Light microscopic immu-nohistochemical analysis of the distribution of group II phospholipase A2 in human digestive organs. J Histochem Cytochem 1992; 40: 1659— 64.
   PubMed Web of Science ®Google Scholar
• Nevalainen TJ, Grönroos JM, Kallajoki M. Expression of group II phospholipase A2 in the human gastrointestinal tract. Lab Invest 1995; 72: 201–8.
   PubMed Web of Science ®Google Scholar
• Nevalainen TJ, Men i KM, Niemi M. Synovial-type (group II) phospholipase A2 human seminal plasma. Andrologia 1993; 25: 355–8.
   PubMed Web of Science ®Google Scholar
• Crowl RM, Stoller TJ, Conroy RR, Stoner CR. Induction of phospholipase A2 gene expression in human hepatoma cells by mediators of the acute phase response. J Biol Chem 1991; 266: 2647–51.
   PubMed Web of Science ®Google Scholar
• Nevalainen T. Review: Serum phospholipases A2 in inflammatory diseases. Clin Chem 1993; 39: 2453–9.
   PubMed Web of Science ®Google Scholar
• Minami T, Tojo H, Shinomura Y, Komatsubara T, Matsuzawa Y, Okamoto M. Elevation of phospholipase A2 protein in sera of patients with Crohn's disease and ulcerative colitis. Am J Gastroenterol 1993; 88: 1076–80.
   PubMed Web of Science ®Google Scholar
• Haapamäki MM, Grönroos JM, Nurmi H, Soderlund K, Peuravuori H, Alanen K, et al. Elevated group II phospholipase A2 mass con-centrations in serum and colonic mucosa in Crohn's disease. Clin Chem Lab Med 1998; 36: 751–5.
   PubMed Web of Science ®Google Scholar
• Andersen S, Sjursen W, Laegreid A, Volden G, Johansen B. Elevated expression of human non-pancreatic phospholipase A2 in psoriatic tissue. Inflammation 1994; 18: 1–12.
   Google Scholar
• Minami T, Tojo H, Shinomura Y, Matsuzawa Y, Okamoto M. Increased group II phospholipase A2 in colonic mucosa of patients with Crohn's disease and ulcerative colitis. Gut 1994; 35: 1593–8.
   Google Scholar
• Haapamäki MM, Grönroos JM, Nurmi H, Alanen K, Kallajoki M, Nevalainen TJ. Gene expression of group II phospholipase A2 in intestine in ulcerative colitis. Gut 1997; 40: 95— 101.
   PubMed Web of Science ®Google Scholar
• Haapamäki MM, Grönroos JM, Nurmi H, Alanen K, Nevalainen TJ. Gene expression of group II phospholipase A2 in intestine in Crohn's disease. Am J Gastroenterol 1999: 94: 713–20.
   PubMed Web of Science ®Google Scholar
• Blackstone MO. Inflammatory bowel disease. In Blackstone MO, editor. Endoscopic interpretation. New York: Raven Press, 1984: 475.
   Google Scholar
• Matts S. The value of rectal biopsy in the diagnosis of ulcerative colitis. Q J Med 1961; 30: 393 —407.
   PubMedGoogle Scholar
• Nevalainen T, Kortesuo P, Rintala E, Märki F. Immunochemical detection of group I and group II phospholipases A2 in human serum. Clin Chem 1992; 38: 1824–9.
   Google Scholar
• Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248–54.
   PubMed Web of Science ®Google Scholar
• Grönroos JM, Kuttila K, Nevalainen TJ. Group II phospholipase A2 in serum in critically ill surgical patients. Crit Care Med 1994; 22: 956–9.
   Google Scholar
• Haapamäki MM, Grönroos JM, Pekkala E, Jokilammi-Siltanen A, Irjala K, Lertola K, et al. Serum phospholipases A2 in patients undergoing panproctocolectomy because of severe ulcerative colitis. Eur J Clin Chem Clin Biochem 1997; 35: 749— 54.
   PubMedGoogle Scholar
• Minami T, Shinomura Y, Miyagawa J, Tojo H, Okamoto M, Matsuzawa Y. Immunohistochem-ical localization of group II phospholipase A2 in colonic mucosa of patients with inflammatory bowel disease. Am J Gastroenterol 1997; 92: 289— 92.
   PubMed Web of Science ®Google Scholar
• Nevalainen TJ, Kallajoki M, Pesonen E, Andersson S, Kärkkäinen P, Höckerstedt K. Origin of circulating group II phospholipase A2 in hepatocytes in a patient with epitheloid hemangioendothelioma of the liver. Lab Invest 1996; 74: 585–91.
   Google Scholar
• Balsinde J, Dennis EA. Distinct roles in signal transduction for each of the phospholipase A2 enzymes present in P388D1 macrophages. J Biol Chem 1996; 271: 6758–65.
   PubMed Web of Science ®Google Scholar
• Weinrauch Y, Elsbach P, Madsen LM, Foreman A, Weiss J. The potent anti-Staphylococcus aureus activity of a sterile rabbit inflammatory fluid is due to a 14-kD phospholipase A2. J Clin Invest 1996; 97: 250–7.
   Google Scholar
• Monajemi H, Meenan J, Lamping R, Obradov DO, Radema SA, Trown PW, et al. Inflammatory bowel disease is associated with increased mucosal levels of bactericidal/permeability-increasing pro-tein. Gastroenterology 1996; 110: 733 — 9.
   PubMed Web of Science ®Google Scholar
• Haapamäki MM, Häggblom J-0, Grönroos JM, Pekkala E, Alanen K, Nevalainen TJ. Bactericidal/ permeability-increasing protein in colonic mucosa in ulcerative colitis. Hepatogastroenterology. In press.
   Google Scholar
• Haselmann J, Goppelt Struebe M. Glucocorticoids inhibit oncostatin M-induced phospholipase A2 gene expression in human hepatoma cells. Cyto-kine 1997; 9: 199–205.
   PubMed Web of Science ®Google Scholar
• Pruzanski W, Stefanski E, Vadas P, Ramamurthy NS. Inhibition of extracellular release of proin-flammatory secretory phospholipase A2 (5PLA2) by sulfasalazine: a novel mechanism of anti-inflammatory activity. Biochem Pharmacol 1997; 53: 1901–7.
   PubMed Web of Science ®Google Scholar